A new clot-busting drug called tenecteplase can be administered in seconds rather than through an hour-long infusion; studies ...

A new study suggests that the 0.25-mg/kg dose of the thrombolytic tenecteplase (TNK) is just as good at facilitating reperfusion of the blocked artery in patients with ischemic large-vessel stroke ...

Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial. However, there were some encouraging trends, and ...

Please provide your email address to receive an email when new articles are posted on . A 0.4 mg/kg dose of tenecteplase administered before endovascular thrombectomy in patients with large vessel ...

Stroke survivors were more likely to have little or no disability after 90 days if a clot was removed from a large brain artery followed by the injection of the clot-dissolving medication tenecteplase ...

For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according ...